Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_assertion type Assertion NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_head.
- NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_assertion description "[We describe a patient with acute myelogenous leukemia (AML) with t(16;21)(p11;q22) translocation, whose minimal residual disease (MRD) both in cerebrospinal fluid (CSF) and bone marrow (BM) was monitored by reverse transcriptase-polymerase chain reaction (RT-PCR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_provenance.
- NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_assertion evidence source_evidence_literature NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_provenance.
- NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_assertion SIO_000772 9549830 NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_provenance.
- NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_assertion wasDerivedFrom befree-20140225 NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_provenance.
- NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_assertion wasGeneratedBy ECO_0000203 NP168413.RAC8P3BeMo39GJWQ7unOWriajh9ApdBIwzenDtyRsF5-g130_provenance.